Join Lindsay's Battle with Dermatomyositis

Support Lindsay Guentzel during her 5-week clinical trial in Denver, Colorado.

Lindsay Guentzel was diagnosed with Dermatomyositis associated with Antisynthetase Syndrome, a rare and incurable autoimmune disease in 2023. Since her diagnosis, Lindsay's full-time job has become finding, attending, and recovering from treatments, all while navigating insurance, and advocating for herself and other patients with this rare, incurable disease.

Lindsay spent six months navigating insurance battles, rescheduled trips, and endless phone calls in an attempt to get on a clinical trial and QUALIFIED!

Lindsay began her clinical trial in Denver in early March. On Sunday, April 13, she travels back to Denver for 5 weeks where she will begin a series of intensive treatments including chemo and T-cell infusions.

Sponsor coverage varies for clinical trials, leaving Lindsay responsible for the majority of costs related to her support system. We want Lindsay to focus on healing, have the support she needs present, and not worry about financial burdens.

Our goal is to raise $6,000 for Lindsay's 5-week clinical trial. Every dollar will offset this financial burden for Lindsay and her support system by helping to cover meals, lodging, and transportation.

Follow Lindsay's journey on instagram at @LindsayGuentzel or via her blog at LindsayGuentzel.com.

To learn more about Dermatomyositis and the Myositis Association, visit myositis.org